Onesource Specialty Pharma Limited has informed the Exchange regarding a press release dated November 11, 2025, titled "Financial results for the quarter ended September 30, 2025".
ONESOURCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Onesource Specialty Pharma Limited has informed NSE about a press release dated November 11, 2025, titled 'Financial results for the quarter ended September 30, 2025.' This is a routine intimation notifying the exchange that the company has issued its quarterly earnings press release. The actual detailed numbers (revenue, profit, margins) are contained in the press release itself rather than in this filing. Q2 FY26 covers the July-September 2025 quarter. Investors should refer to the linked press release or the separately filed financial results for the specific figures and management commentary.
This is a procedural filing with no direct stock price impact, but it signals that quarterly results are now public. Investors should review the actual press release and the detailed financial results filing for revenue growth, profit trends, and outlook to assess the company's quarterly performance.